Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna’s mRNA Combination Vaccine Against Influenza and COVID-19

COMBRIAX is the world's first flu plus COVID combination vaccine to receive marketing authorization and Moderna's ...

Europe clears first flu/COVID combo shot from Moderna

Moderna Inc. MRNA shares are up on Tuesday as the company received marketing authorization for its mCOMBRIAX vaccine, the ...

Moderna wins EU approval for combined flu, COVID shot for older adults

April 21 (Reuters) - Moderna said on Tuesday the European Commission had approved its combination vaccine for the prevention ...
Medscape

Low COVID and Flu Vaccine Uptake Among Risk Groups in Europe

Uptake of seasonal influenza and COVID-19 vaccination among risk groups such as older adults in many European Union/European Economic Area member states between 2023 and 2024 has been suboptimal, ...
MPR

Protein-Based COVID-19 Vaccine Demonstrates Superior Tolerability to mRNA Comparator

Phase 4 COMPARE trial data show Nuvaxovid was associated with lower reactogenicity and fewer daily activity disruptions than mNEXSPIKE.
TCTMD

European Experts Provide Advice on Managing CV Effects of COVID-19

A new consensus document from five subspecialty associations within the European Society of Cardiology gives recommendations for managing the cardiovascular consequences of COVID-19, spanning the ...